Showing results (921-930 of 1,604) with videos related to
Sort By:
Pageof 161
JAMA Dermatology|May 14, 2015
Technology and Technique Standards for Camera-Acquired Digital Dermatologic Images: A Systematic ReviewElizabeth A Quigley, Barbara A Tokay, Sarah T Jewell, et al.JAMA Dermatology|July 9, 2015
Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 MutationPedram Gerami, Oriol Yélamos, Christina Y Lee, et al.JAMA Dermatology|April 25, 2015
In Vivo Multiphoton Microscopy of Basal Cell CarcinomaMihaela Balu, Christopher B Zachary, Ronald M Harris, et al.JAMA Dermatology|September 3, 2025
Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular EventsMaxime Raby, Frederic Balusson, Emmanuel Oger, et al.JAMA Dermatology|September 3, 2025
Local Recurrence and Survival in Patients With Melanoma In SituClio Dessinioti, Aggeliki Befon, Mihaella Plaka, et al.JAMA Dermatology|August 4, 2016
Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During ChildhoodBéatrice Vergier, Elodie Laharanne, Martina Prochazkova-Carlotti, et al.JAMA Dermatology|June 25, 2015
Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed TherapyBrittany G Craiglow, Brett A KingJAMA Dermatology|July 21, 2016
Cyclosporine Treatment of Drug-Induced Hypersensitivity SyndromeMark G Kirchhof, Aaron Wong, Jan P DutzJAMA Dermatology|July 21, 2016
Symptomatic Congenital Hemangioma and Congenital Hemangiomatosis Associated With a Somatic Activating Mutation in GNA11Tracy Funk, Young Lim, Ann M Kulungowski, et al.JAMA Dermatology|July 23, 2015
Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic MelanomaGiuliana Carlos, Rachael Anforth, Arthur Clements, et al.Pageof 161